Approval · Notice of Compliance 18295 · 2016

THYROGEN: Notice of Compliance 18295

Issued July 22, 2016

A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.

Notice number: 18295
Date: July 22, 2016
Company: Genzyme Canada A Division Of Sanofi-Aventis Canada Inc
Product type: Biologic
Submission: Supplement to a New Drug Submission (SNDS), supplement
Submission class: Other
Reason: Additional manufacturing facility

Products in this notice

Brand	DIN	Status today
THYROGEN	Not yet assigned	—

Medicinal ingredients

THYROTROPIN ALFA 0.9 MG per ML